ISSN: 2155-6105

Revista de investigación y terapia de adicciones

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Indexado en
  • Índice de fuentes CAS (CASSI)
  • Índice Copérnico
  • Google Académico
  • sherpa romeo
  • Abrir puerta J
  • Revista GenámicaBuscar
  • Claves Académicas
  • TOC de revistas
  • SeguridadIluminado
  • Infraestructura Nacional del Conocimiento de China (CNKI)
  • Biblioteca de revistas electrónicas
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catálogo en línea SWB
  • Biblioteca Virtual de Biología (vifabio)
  • publones
  • Fundación de Ginebra para la educación y la investigación médicas
  • Pub Europeo
  • ICMJE
Comparte esta página

Abstracto

Abstaining Opioid Drugs as a Possible Risk Factor for Graves’ Disease

Shahin Banaei Boroujeni , Azam Ghanei, Golnaz Malekzadeh, Mehdi Mirzaei-Alvijeh and Ehsan Zarepur

Introduction: Graves’ disease is an autoimmune disease with obscure etiology. It may be associated with an underlying emotional stress of any kind. On the other hand abstaining opioid drugs’ addiction is a major stress that can develop this disease. Confronting several patients who were attacked by Graves’ disease, with the history of opioid abstinence led us to investigate them more and report the findings. Methods: In this case series study 46 patients who were addicted to opioid drugs and have abandoned it less than 9 months from the admission time to endocrinologist were investigated. They all presented the signs and symptoms of Graves’ disease. Thyroid function tests consist of T3, T4 and TSH were measured for each patient and compared against the ones before opioid abstinence. Statistical analysis was performed by using T- Test and SPSS 18.0 software. Results: 46 patients, which include 2 women and 44 men were studied. The lab results before opioid abstinence confirmed that all were euthyriod. The serum level of T3 increased from 126.3026 ± 34.2356 ng/dl to 311.3696 ± 79.80932 ng/dl after opioid abstinence, this level for T4 also increased from 8.1130 ± 1.54684 ng/dl to 18.4674 ± 3.5589 ng/dl. The difference between thyroid hormone before and after opioid abstinence was statistically significant (P<0.05). The serum level of TSH decreased from 1.3457 ± 0.68043 ng/dl to 0.0289 ± 0.0294 ng/dl which was also statistically significant (P<0.05). Conclusion: Opioid drugs’ abstinence may develop Graves’ disease. More investigation is suggested.